What is Stim?
Established in 2002, Stim operates as a premier provider of Intraoperative Neuromonitoring (IONM) services, delivering essential real-time data to surgical teams during complex procedures involving the brain and spine. The company distinguishes itself through a rigorous commitment to clinical excellence, employing a nationwide network of CNIM-certified neurophysiologists. By providing 24/7 monitoring capabilities, Stim effectively bridges the gap between advanced neurological diagnostics and surgical intervention, thereby reducing the incidence of iatrogenic injury. Their business model is deeply integrated into the hospital ecosystem, serving as a vital partner for healthcare facilities that prioritize high-acuity surgical outcomes and operational efficiency in the operating room.
How much funding has Stim raised?
Stim has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Stim
PPP
Public-Private Partnership
What's next for Stim?
With the successful closure of this late-stage financing round, Stim is well-positioned to scale its service delivery infrastructure and potentially expand its technological capabilities. The strategic allocation of this capital will likely focus on enhancing the company's proprietary monitoring platforms and deepening its penetration into high-growth surgical markets. As the demand for specialized neuro-monitoring continues to rise in response to an aging population and the increasing complexity of spinal and cranial surgeries, Stim is poised to leverage its established reputation to capture additional market share. Future growth trajectories will likely involve optimizing service delivery models and exploring potential synergies within the broader healthcare technology ecosystem to maintain its competitive advantage in the IONM sector.
See full Stim company page
